Qube Research & Technologies LTD Precision Biosciences Inc Transaction History

Qube Research & Technologies LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.34 - $0.69 $87 - $176	256 New	256 $0
Q1 2023 May 15, 2023	SELL	$0.7 - $1.41 $30,412 - $61,258	-43,446 Reduced 76.79%	13,133 $9,000
Q4 2022 Feb 14, 2023	BUY	$0.97 - $45.0 $19,792 - $918,225	20,405 Added 56.41%	56,579 $67,000
Q3 2022 Nov 14, 2022	SELL	$1.22 - $40.8 $44,309 - $1.48 Million	-36,319 Reduced 50.1%	36,174 $47,000
Q2 2022 Aug 15, 2022	BUY	$1.15 - $3.34 $83,366 - $242,126	72,493 New	72,493 $116,000
Q1 2022 May 09, 2022	SELL	$2.96 - $7.76 $96,963 - $254,202	-32,758 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$7.4 - $11.66 $242,409 - $381,958	32,758 New	32,758 $242,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $550M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.